Allergan Eyes Posurdex Approval In Late 2007
This article was originally published in The Pink Sheet Daily
The company also pursuing potential macular degeneration indication.
You may also be interested in...
Company is counting on a confirmatory trial initiated in 2005 to satisfy FDA concerns regarding the glaucoma treatment.
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13